# US 2013/0281667 A1 · Uses of spatial configuration to modulate protein function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0281667 A1
- Document ID: US20130281667A1
- Status: Published application
- Kind: A1
- Application number: 13/923,378
- Filed: 2013-06-21
- Published: 2013-10-24
- Earliest claimed: 2001-02-28
- Applicants: Superlab Far East Limited
- Inventors: Guangwen WEI
- Web page: https://patentgrep.com/patent/US20130281667A1

## CPC

- C07K 14/56: IFN-alpha
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 15/67: General methods for enhancing the expression
- C12P 21/06: produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

This invention provides a set of methods for modulating protein spatial configuration. First, select the amino-acid codon for encoding the target protein according to host codon usage. Second, choose combinations which can modulate the spatial configuration and construct into different vectors which can transfect a series of hosts. Third, choose the vector promoter by monitoring a combination of base pairs after combining the code sequence of the promoter and the target protein. Finally, choose the appropriate expression host to express the target protein, refold and purify, measure the activity and spatial configuration.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

A method for modulating a function of a first protein that comprises a primary amino acid sequence without changing the primary amino acid sequence of the first protein, comprising the steps of:
a) altering codon usage of a first nucleotide sequence encoding the first protein, thereby obtaining a second nucleotide sequence comprising altered codons;
b) expressing the second nucleotide sequence to obtain a second protein; and
c) comparing the second protein with the first protein, wherein an increase in function or identification of a new function of the second protein indicates that the function of the first protein has been modulated.

### Claim 18 (depends on 17)

The method of claim 17, wherein altering the codon usage comprises altering and/or using a single codon to encode a specified amino acid residue, wherein when the amino acid residue is isoleucine, the encoding codon is ATC, when the amino acid residue is leucine, the encoding codon is CTG, when the amino acid residue is valine, the encoding codon is GTT, when the amino acid residue is phenylalanine, the encoding codon is TTC, when the amino acid residue is cysteine, the encoding codon is TGC, when the amino acid residue is alanine, the encoding codon is GCT, when the amino acid residue is proline, the encoding codon is CCG, when the amino acid residue is threonine, the encoding codon is ACC, when the amino acid residue is serine, the encoding codon is TCC, when the amino acid residue is tyrosine, the encoding codon is TAC, when the amino acid residue is glutamine, the encoding codon is CAG, when the amino acid residue is histidine, the encoding codon is CAC, when the amino acid residue is glutamic acid, the encoding codon is GAA, when the amino acid residue is aspartic acid, the encoding codon is GAC, when the amino acid residue is lysine, the encoding codon is AAA, and when the amino acid residue is arginine, the encoding amino acid residue is CGT.

### Claim 19 (depends on 17)

The method of claim 17, wherein expressing the second nucleotide sequence comprises expressing the second nucleotide sequence in an E. coli host cell.

### Claim 20

An isolated polynucleotide comprising a nucleotide sequence that encodes a recombinant polypeptide, wherein the nucleotide sequence comprises a plurality of codons, wherein each codon encodes an amino acid residue, and wherein each amino acid residue that is the same in the polypeptide is encoded by the same codon.

### Claim 21 (depends on 20)

The polynucleotide of claim 20, wherein when the amino acid residue is isoleucine, the encoding codon is ATC, when the amino acid residue is leucine, the encoding codon is CTG, when the amino acid residue is valine, the encoding codon is GTT, when the amino acid residue is phenylalanine, the encoding codon is TTC, when the amino acid residue is cysteine, the encoding codon is TGC, when the amino acid residue is alanine, the encoding codon is GCT, when the amino acid residue is proline, the encoding codon is CCG, when the amino acid residue is threonine, the encoding codon is ACC, when the amino acid residue is serine, the encoding codon is TCC, when the amino acid residue is tyrosine, the encoding codon is TAC, when the amino acid residue is glutamine, the encoding codon is CAG, when the amino acid residue is histidine, the encoding codon is CAC, when the amino acid residue is glutamic acid, the encoding codon is GAA, when the amino acid residue is aspartic acid, the encoding codon is GAC, when the amino acid residue is lysine, the encoding codon is AAA, and when the amino acid residue is arginine, the encoding amino acid residue is CGT.

### Claim 22 (depends on 20)

A method of enhanced production of a polypeptide comprising introducing the polynucleotide of claim 20 into a host cell, culturing such host cell and obtaining the polypeptide from such host cell culture.

### Claim 23

A method for modulating a function of a first interferon that comprises a primary amino acid sequence without changing the primary amino acid sequence of the first interferon, comprising the steps of:
a) altering codon usage of a first nucleotide sequence encoding the first interferon, thereby obtaining a second nucleotide sequence comprising altered codons that encodes a second interferon;
b) expressing the second nucleotide sequence to obtain the second interferon; and
c) comparing the second interferon with the first interferon, wherein an increase in function or identification of a new function of the second interferon indicates that the function of the first interferon has been modulated.

### Claim 24 (depends on 23)

The method of claim 23, wherein altering the codon usage comprises altering and/or using a single codon to encode a specified amino acid residue, wherein when the amino acid residue is isoleucine, the encoding codon is ATC, when the amino acid residue is leucine, the encoding codon is CTG, when the amino acid residue is valine, the encoding codon is GTT, when the amino acid residue is phenylalanine, the encoding codon is TTC, when the amino acid residue is cysteine, the encoding codon is TGC, when the amino acid residue is alanine, the encoding codon is GCT, when the amino acid residue is proline, the encoding codon is CCG, when the amino acid residue is threonine, the encoding codon is ACC, when the amino acid residue is serine, the encoding codon is TCC, when the amino acid residue is tyrosine, the encoding codon is TAC, when the amino acid residue is glutamine, the encoding codon is CAG, when the amino acid residue is histidine, the encoding codon is CAC, when the amino acid residue is glutamic acid, the encoding codon is GAA, when the amino acid residue is aspartic acid, the encoding codon is GAC, when the amino acid residue is lysine, the encoding codon is AAA, and when the amino acid residue is arginine, the encoding amino acid residue is CGT.

### Claim 25 (depends on 23)

The method of claim 23, wherein expressing the second nucleotide sequence comprises expressing the nucleotide sequence in an E. coli host cell.

### Claim 26

An isolated polynucleotide comprising a nucleotide sequence that encodes a recombinant interferon, wherein the nucleotide sequence comprises a plurality of codons, wherein each codon encodes an amino acid residue, and wherein each amino acid residue that is the same in the interferon is encoded by the same codon.

### Claim 27 (depends on 26)

The polynucleotide of claim 26, wherein when the amino acid residue is isoleucine, the encoding codon is ATC, when the amino acid residue is leucine, the encoding codon is CTG, when the amino acid residue is valine, the encoding codon is GTT, when the amino acid residue is phenylalanine, the encoding codon is TTC, when the amino acid residue is cysteine, the encoding codon is TGC, when the amino acid residue is alanine, the encoding codon is GCT, when the amino acid residue is proline, the encoding codon is CCG, when the amino acid residue is threonine, the encoding codon is ACC, when the amino acid residue is serine, the encoding codon is TCC, when the amino acid residue is tyrosine, the encoding codon is TAC, when the amino acid residue is glutamine, the encoding codon is CAG, when the amino acid residue is histidine, the encoding codon is CAC, when the amino acid residue is glutamic acid, the encoding codon is GAA, when the amino acid residue is aspartic acid, the encoding codon is GAC, when the amino acid residue is lysine, the encoding codon is AAA, and when the amino acid residue is arginine, the encoding amino acid residue is CGT.

### Claim 28 (depends on 26)

A vector comprising the polynucleotide of claim 26, further comprising a promoter that is operatively linked to the polynucleotide.

### Claim 29 (depends on 28)

An expression system comprising the vector of claim 28.

### Claim 30 (depends on 28)

A host cell comprising the vector of claim 28.

### Claim 31 (depends on 30)

The host cell of claim 30, wherein the cell is an E. coli cell.

### Claim 32 (depends on 28)

A method of enhanced production of a polypeptide comprising introducing the vector of claim 28 into a host cell, culturing such host cell and obtaining the polypeptide from such host cell culture.

### Claim 33 (depends on 32)

The method of claim 32, wherein the host cell is an E. coli cell.

### Claim 34 (depends on 32)

A polypeptide obtained from the method of claim 32.
